Literature DB >> 10426355

Magnetic resonance spectroscopy: imaging axonal damage in MS.

D L Arnold1.   

Abstract

Recent observations made using magnetic resonance spectroscopy to measure the axonal marker N-acetylaspartate have emphasized the fact that substantial axonal damage occurs in multiple sclerosis, in addition to demyelination. The axonal damage is present both in lesions and normal appearing white matter, progresses over time, and correlates with clinical disability. These observations, together with observations demonstrating that adaptations of sodium channels can restore conduction in demyelinated axons, have led to the hypothesis that axonal damage may be responsible for a significant proportion of the chronic disability that accrues in MS.

Entities:  

Mesh:

Year:  1999        PMID: 10426355     DOI: 10.1016/s0165-5728(99)00074-0

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  11 in total

1.  Reduced expression of plasma membrane calcium ATPase 2 and collapsin response mediator protein 1 promotes death of spinal cord neurons.

Authors:  M P Kurnellas; H Li; M R Jain; S N Giraud; A B Nicot; A Ratnayake; R F Heary; S Elkabes
Journal:  Cell Death Differ       Date:  2010-05-21       Impact factor: 15.828

2.  Correlation of multiple sclerosis measures derived from T2-weighted, T1-weighted, magnetization transfer, and diffusion tensor MR imaging.

Authors:  G Iannucci; M Rovaris; L Giacomotti; G Comi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

3.  Axonal damage is T cell mediated and occurs concomitantly with demyelination in mice infected with a neurotropic coronavirus.

Authors:  A A Dandekar; G F Wu; L Pewe; S Perlman
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Effects of glatiramer acetate and interferon-beta on neurodegeneration in a model of multiple sclerosis: a comparative study.

Authors:  Katharina Maier; Antje V Kuhnert; Naimeh Taheri; Muriel B Sättler; Maria K Storch; Sarah K Williams; Mathias Bähr; Ricarda Diem
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

5.  Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.

Authors:  Veronique E Miron; Samuel K Ludwin; Peter J Darlington; Andrew A Jarjour; Betty Soliven; Timothy E Kennedy; Jack P Antel
Journal:  Am J Pathol       Date:  2010-04-22       Impact factor: 4.307

6.  Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice.

Authors:  H Li; S H Li; Z X Yu; P Shelbourne; X J Li
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

7.  Evaluation of corticospinal axon loss by fluorescent dye tracing in mice with experimental autoimmune encephalomyelitis.

Authors:  Zhongwu Liu; Yi Li; Jing Zhang; Stanton Elias; Michael Chopp
Journal:  J Neurosci Methods       Date:  2007-08-25       Impact factor: 2.390

Review 8.  Axonal injury in multiple sclerosis.

Authors:  Kottil W Rammohan
Journal:  Curr Neurol Neurosci Rep       Date:  2003-05       Impact factor: 5.081

9.  Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury.

Authors:  K Akassoglou; K W Kombrinck; J L Degen; S Strickland
Journal:  J Cell Biol       Date:  2000-05-29       Impact factor: 10.539

10.  Metabolic changes in normal appearing white matter in multiple sclerosis patients using multivoxel magnetic resonance spectroscopy imaging.

Authors:  Jubao Sun; Hao Song; Yong Yang; Kun Zhang; Xiuju Gao; XiaoPan Li; Li Ni; Pan Lin; Chen Niu
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.